News

The Clinical Trial Patient Experience: Balancing Science, Technology, and Humanity
Article

August 21, 2026

The Clinical Trial Patient Experience: Balancing Science, Technology, and Humanity

Read More
How to Evaluate an eCOA Vendor for Global Trials
Blog

August 20, 2026

How to Evaluate an eCOA Vendor for Global Trials

Read More
BYOD vs. Provisioned Devices: Why Participant Choice Should Drive Your eCOA Strategy
Blog

August 20, 2026

BYOD vs. Provisioned Devices: Why Participant Choice Should Drive Your eCOA Strategy

Read More
Strengthen Participant-Site Readiness for Complex Rare Disease Trials
Webinar

June 29, 2026

Strengthen Participant-Site Readiness for Complex Rare Disease Trials

Read More
uMotif Chief Scientific Officer Florence Mowlem PhD Wins PCMG Outsourcing Trailblazer of the Year Award
Press Release

June 23, 2026

uMotif Chief Scientific Officer Florence Mowlem PhD Wins PCMG Outsourcing Trailblazer of the Year Award

Read More
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
Article

June 17, 2026

Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing

Read More
Why are eCOA studies still so challenging? And, how can we make them better?
Blog

June 3, 2026

Why are eCOA studies still so challenging? And, how can we make them better?

Read More
uMotif Announces Andrea Valente is Chief Executive Officer
Press Release

June 1, 2026

uMotif Announces Andrea Valente is Chief Executive Officer

Read More
18 months of FDA’s Core Patient-Reported Outcomes in Cancer Clinical Trials Guidance – have we seen its impact? 
Blog

May 26, 2026

18 months of FDA’s Core Patient-Reported Outcomes in Cancer Clinical Trials Guidance – have we seen its impact? 

Read More